DNAVision
The computed 12-month bankruptcy probability of DNAVision is 0.3% (very low). The company has been active since 2004 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 22 yrs |
| Locations | 1 |
| Publications | 11 |
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2024 | volledig | 19-09-2025 | 2025-00495369 |
| 31-12-2023 | volledig | 29-08-2024 | 2024-00417713 |
| 31-12-2022 | volledig | 31-08-2023 | 2023-00414084 |
| 31-12-2021 | volledig | 13-10-2022 | 2022-20460711 |
| 31-12-2020 | volledig | 21-12-2021 | 2021-81000227 |
| 31-12-2019 | volledig | 30-11-2020 | 2020-74000455 |
| 31-12-2018 | volledig | 21-08-2019 | 2019-48300064 |
| 31-12-2017 | volledig | 24-01-2019 | 2019-02100490 |
| 31-12-2016 | volledig | 09-03-2018 | 2018-06500463 |
| 31-12-2015 | volledig | 30-08-2016 | 2016-52700334 |
| NACE primary | 72109 |
| Legal form | Public limited company(014) |
| Incorporation | 13-05-2004 |
| Status | Active |
| Postal code | 6041 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates — not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 52028B0318/00G002 | Wallonia | 5,399 m² | — | — |
A single timeline of everything that happened to this company — publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
13-01-2022 3 directors appointed
- Laurent Eric René Alexandre — Administrateur unique
- Guy Helin — Bestuurder
- Laurent Eric René Alexandre — Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "administrateur unique",
"person": {
"rrn": null,
"name": "Laurent Eric Ren\u00E9 Alexandre",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Guy Helin",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Laurent Eric Ren\u00E9 Alexandre",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0865.300.475",
"name_full": "DNA Vision"
}
}13-01-2022 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": true
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0865.300.475",
"name_full": "DNA Vision"
},
"legal_form_change": {
"new": "soci\u00E9t\u00E9 anonyme",
"old": "soci\u00E9t\u00E9 anonyme",
"changed": false
}
}22-01-2019 Capital increase of €630,000 to €630,000
- €0 → €630.000
- Inbreng in natura · Apport en nature
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 630000,
"delta_eur": 630000,
"before_eur": 0,
"contribution_type": "natura"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0865.300.475",
"name_full": "DNAVision"
}
}20-09-2016 2 directors appointed
- Pierre Alcover — Commissaire
- Henri Vaesen — Commissaire
Technical details
{
"events": [
{
"kind": "director_in",
"role": "commissaire",
"person": {
"rrn": null,
"name": "Pierre Alcover",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "commissaire",
"person": {
"rrn": null,
"name": "Henri Vaesen",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0865.300.475",
"name_full": "DNA VISION"
}
}13-09-2016 Laurent Alexandre appointed as actionnaire
- Laurent Alexandre — Actionnaire
Technical details
{
"events": [
{
"kind": "director_in",
"role": "actionnaire",
"person": {
"rrn": null,
"name": "Laurent Alexandre",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0865.300.475",
"name_full": "DNAVision"
}
}13-09-2016 Capital increase of €223,648.60 to €223,648.60
- €0 → €223.648,60
- Inbreng in natura · Apport en nature
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 223648.6,
"delta_eur": 223648.6,
"before_eur": 0,
"contribution_type": "natura"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0865.300.475",
"name_full": "DNAVision"
}
}19-06-2015 Capital increase of €202,537.31 to €202,537.31
- €0 → €202.537,31
- Inbreng in natura · Apport en nature
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 202537.31,
"delta_eur": 202537.31,
"before_eur": 0,
"contribution_type": "natura"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0865.300.475",
"name_full": "DNAVision"
}
}19-06-2015 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0865.300.475",
"name_full": "DNAVision"
},
"legal_form_change": {
"new": "soci\u00E9t\u00E9 anonyme",
"old": "soci\u00E9t\u00E9 anonyme",
"changed": false
}
}15-02-2011 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0865.300.475",
"name_full": "DNAVision"
},
"legal_form_change": {
"new": "",
"old": "Soci\u00E9t\u00E9 anonyme",
"changed": false
}
}15-02-2011 Capital increase of €1,500,000 to €2,331,000
- €831.000 → €2.331.000
- Inbreng in natura · Apport en nature
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 2331000,
"delta_eur": 1500000,
"before_eur": 831000,
"contribution_type": "natura"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0865.300.475",
"name_full": "DNAVision"
}
}17-11-2010 Publication in the Belgian Official Gazette — Miscellaneous
Technical details
{
"stage": "proposal",
"notary": {
"name": "Sophie Maquet",
"firm_city": null,
"firm_name": null,
"office_city": "Charleroi",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2010-11-17",
"filing_date": null,
"act_kind_objet": "D\u00E9p\u00F4t du projet de fusion"
},
"decision": {
"body": "algemene_vergadering",
"act_date": "2010-11-02",
"unanimous": null
},
"conversion": null,
"detected_kind": "merger_absorption",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0865.300.475",
"name": "DNAVision",
"role": "acquiring",
"address": "6041 Gosselies, Avenue Georges Lema\u00EEtre, 25.",
"is_foreign": false,
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_new_company": false,
"jurisdiction_country": "BE"
},
{
"kbo": null,
"name": "DNAVision Agrifood",
"role": "absorbed",
"address": null,
"is_foreign": false,
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_new_company": false,
"jurisdiction_country": "BE"
}
],
"exchange_ratio": null,
"legal_articles": [
"719",
"720"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": 0,
"real_estate_included": false,
"patrimony_description": "La fusion pr\u00E9voit l\u0027absorption par DNAVision de DNAVision Agrifood, soci\u00E9t\u00E9 absorb\u00E9e. Le patrimoine de la soci\u00E9t\u00E9 absorb\u00E9e est transf\u00E9r\u00E9 int\u00E9gralement \u00E0 la soci\u00E9t\u00E9 absorbante.",
"equity_transferred_eur": null,
"accounting_effective_date": null
},
"subject_company": {
"kbo": "0865.300.475",
"name_full": "DNAVision",
"legal_form": "Soci\u00E9t\u00E9 anonyme"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Sophie Maquet",
"org_rep_person_name": null
},
"summary_narrative": "Le projet de fusion par absorption a \u00E9t\u00E9 \u00E9tabli par les conseils d\u0027administration des soci\u00E9t\u00E9s anonymes DNAVision et DNAVision Agrifood. DNAVision, soci\u00E9t\u00E9 absorbante, pr\u00E9voit l\u0027absorption de DNAVision Agrifood, soci\u00E9t\u00E9 absorb\u00E9e, conform\u00E9ment aux articles 719 et 720 du Code des soci\u00E9t\u00E9s.",
"co_filed_documents": [
"projet de fusion"
],
"detected_real_type": "fusion_proposal",
"referenced_correction": null,
"should_reroute_to_category": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | DNAVision |